February 6, 2026 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on several medicines: Trazimera | European Medicines Agency (EMA) Gilenya | European Medicines Agency (EMA) Erleada | European Medicines Agency (EMA) Prevenar 13 | European Medicines Agency (EMA) Wegovy | European Medicines Agency (EMA) DuoTrav | European Medicines Agency (EMA) Exjade | European Medicines Agency (EMA) Kesimpta | European Medicines Agency (EMA) Azarga | European Medicines Agency (EMA) Yuvanci | European Medicines Agency (EMA)
